A Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following Surgery

NCT03809000 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

188

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: Radiation Therapy
DRUG: Enzalutamide
DRUG: Bicalutamide
DRUG: GnRH analog

Sponsor

RTOG Foundation, Inc.

Collaborators

[object Object]
[object Object]